Ceftriaxone + Sulbactam

What It Is

• Ceftriaxone - a third-generation cephalosporin antibiotic
• Sulbactam - a beta-lactamase inhibitor (not an antibiotic on its own)

Mechanism of Action

• Inhibits bacterial cell wall synthesis by binding to Penicillin-Binding Proteins (PBPs)
• Disrupts peptidoglycan cross-linking, leading to bacterial cell lysis and death
• Bactericidal

• Irreversibly inhibits beta-lactamase enzymes produced by resistant bacteria
• Protects ceftriaxone from being hydrolyzed/inactivated by these enzymes
• Extends ceftriaxone's activity against beta-lactamase-producing organisms
• Also has some intrinsic activity against Acinetobacter species by binding to PBP2 directly

• Jawetz Melnick & Adelbergs Medical Microbiology 28E; Tietz Textbook of Laboratory Medicine 7th Ed.

Spectrum of Activity

Clinical Indications

• Respiratory tract infections - community-acquired pneumonia, acute exacerbations of COPD
• Urinary tract infections - complicated UTIs, pyelonephritis
• Intra-abdominal infections
• Skin and soft tissue infections
• Bone and joint infections (osteomyelitis, septic arthritis)
• Meningitis - preferred agent (CNS penetration is excellent)
• Gonorrhea / PID
• Typhoid fever / enteric fever
• Bacterial endocarditis (HACEK organisms; prophylaxis)
• Lyme disease (disseminated, stage II/III)
• Surgical prophylaxis - colorectal, upper GI, biliary procedures
• Febrile neutropenia
• Syphilis (in penicillin-allergic patients)
• Bacteremia / Sepsis
• Harrison's Principles of Internal Medicine 22E; Goldman-Cecil Medicine; The Washington Manual of Medical Therapeutics; Rosen's Emergency Medicine; Schwartz's Principles of Surgery 11th Ed.

Dosage

• Mild-moderate infections: 1–2 g IV/IM every 12–24 hours (max 4 g/24 hr)
• Severe infections / meningitis: 2 g IV every 12 hours (max 4 g/24 hr)
• Gonorrhea (uncomplicated): <150 kg - 500 mg IM x 1; ≥150 kg - 1 g IM x 1
• Surgical prophylaxis: single dose 30–60 min before procedure

• Mild-moderate: 50–75 mg/kg/24 hr divided Q12–24 hr (max 2 g/24 hr)
• Severe / meningitis: 100 mg/kg/24 hr divided Q12 hr (max 2 g/dose, 4 g/24 hr)
• Harriet Lane Handbook 23rd Ed.

Pharmacokinetics

Note: There is a pharmacokinetic mismatch - sulbactam's half-life is shorter than ceftriaxone's, which raises questions about optimal dosing. Recent hollow-fiber model studies (2026) suggest "post-beta-lactamase inhibitor effect" (PLIE) may help bridge this gap.

Adverse Effects

• Injection site pain, induration, phlebitis
• Diarrhea (antibiotic-associated)
• Elevated liver enzymes (AST, ALT - up to 3%)
• Rash

• Biliary sludge / pseudolithiasis (ceftriaxone precipitates in bile - reversible)
• Hyperbilirubinemia / jaundice
• Clostridioides difficile diarrhea / colitis
• Agranulocytosis (rare, >10 days use, total dose >20 g)
• Convulsions (rare)
• Anaphylaxis / hypersensitivity

• Stevens-Johnson syndrome / Toxic Epidermal Necrolysis
• Acute generalized exanthematous pustulosis (AGEP)

Key Contraindications & Cautions

• Neonates (<28 days): CONTRAINDICATED with IV calcium-containing solutions - fatal ceftriaxone-calcium precipitates have been reported in lungs and kidneys
• Hyperbilirubinemia in neonates - ceftriaxone displaces bilirubin from albumin
• Penicillin/cephalosporin allergy - cross-reactivity possible
• Hepatic/biliary disease - use with caution (significant biliary clearance)
• Renal impairment - dose adjustment generally not required unless combined with hepatic failure

Drug Interactions

• IV Calcium-containing solutions - absolute contraindication in neonates; flush IV lines thoroughly in all ages before and after
• Aminoglycosides - physical incompatibility; do not mix in same infusion
• Warfarin - may potentiate anticoagulant effect

False Laboratory Interferences

• False-positive urine glucose (Benedict's, Fehling's, Clinitest methods) - use enzymatic tests (Clinistix, Tes-Tape) instead
• False elevation of serum/urine creatinine (Jaffe method)
• Coombs test positivity (positive direct antiglobulin test)
• Henry's Clinical Diagnosis and Management by Laboratory Methods; Harriet Lane Handbook 23rd Ed.

Summary